Do Patients with Bronchiectasis Have an Increased Risk of Developing Lung Cancer? A Systematic Review
- PMID: 36836816
- PMCID: PMC9961135
- DOI: 10.3390/life13020459
Do Patients with Bronchiectasis Have an Increased Risk of Developing Lung Cancer? A Systematic Review
Abstract
Background: Initial evidence supports the hypothesis that patients with non-cystic fibrosis bronchiectasis (NCFB) have a higher risk of lung cancer. We systematically reviewed the available literature to define the characteristics of lung malignancies in patients with bronchiectasis and the characteristics of patients who develop bronchiectasis-associated lung cancer.
Method: This study was performed based on the PRISMA guidelines. The review protocol was registered in PROSPERO.
Results: The frequency rates of lung cancer in patients with NCFB ranged from 0.93% to 8.0%. The incidence rate was 3.96. Cancer more frequently occurred in the elderly and males. Three studies found an overall higher risk of developing lung cancer in the NCFB population compared to the non-bronchiectasis one, and adenocarcinoma was the most frequently reported histological type. The effect of the co-existence of NCFB and COPD was unclear.
Conclusions: NCFB is associated with a higher risk of developing lung cancer than individuals without NCFB. This risk is higher for males, the elderly, and smokers, whereas concomitant COPD's effect is unclear.
Keywords: COPD; bronchiectasis; hazard risk; lung cancer.
Conflict of interest statement
The authors declare no conflict of interest.
Figures




Similar articles
-
The effect of N-acetylcysteine in patients with non-cystic fibrosis bronchiectasis (NINCFB): study protocol for a multicentre, double-blind, randomised, placebo-controlled trial.BMC Pulm Med. 2022 Nov 7;22(1):401. doi: 10.1186/s12890-022-02202-9. BMC Pulm Med. 2022. PMID: 36344940 Free PMC article.
-
Incidence of patients with non-cystic fibrosis bronchiectasis in Germany - A healthcare insurance claims data analysis.Respir Med. 2019 May;151:121-127. doi: 10.1016/j.rmed.2019.04.007. Epub 2019 Apr 9. Respir Med. 2019. PMID: 31047108
-
Assessing effects of inhaled antibiotics in adults with non-cystic fibrosis bronchiectasis--experiences from recent clinical trials.Expert Rev Respir Med. 2018 Sep;12(9):769-782. doi: 10.1080/17476348.2018.1503540. Epub 2018 Aug 3. Expert Rev Respir Med. 2018. PMID: 30025482 Review.
-
Ciprofloxacin Dry Powder for Inhalation in Patients with Non-Cystic Fibrosis Bronchiectasis or Chronic Obstructive Pulmonary Disease, and in Healthy Volunteers.J Aerosol Med Pulm Drug Deliv. 2017 Feb;30(1):53-63. doi: 10.1089/jamp.2015.1282. Epub 2016 Jul 22. J Aerosol Med Pulm Drug Deliv. 2017. PMID: 27448179 Clinical Trial.
-
Gender differences in non-cystic fibrosis bronchiectasis severity and bacterial load: the potential role of hormones.Ther Adv Respir Dis. 2021 Jan-Dec;15:17534666211035311. doi: 10.1177/17534666211035311. Ther Adv Respir Dis. 2021. PMID: 34520299 Free PMC article. Review.
Cited by
-
Lung bronchiectasisas a paradigm of the interplay between infection and colonization on plastic modulation of the pre-metastatic niche.Front Oncol. 2024 Oct 14;14:1480777. doi: 10.3389/fonc.2024.1480777. eCollection 2024. Front Oncol. 2024. PMID: 39469649 Free PMC article.
-
Te Oranga Pūkahukahu research programme: intentional steps towards a national equity-focused lung cancer screening programme in Aotearoa New Zealand.J R Soc N Z. 2025 Feb 12;55(5):1322-1337. doi: 10.1080/03036758.2025.2458037. eCollection 2025. J R Soc N Z. 2025. PMID: 40718036 Free PMC article.
-
Thoracic Malignancies: From Prevention and Diagnosis to Late Stages.Life (Basel). 2025 Jan 21;15(2):138. doi: 10.3390/life15020138. Life (Basel). 2025. PMID: 40003547 Free PMC article.
References
-
- McDonnell M.J., Aliberti S., Goeminne P.C., Restrepo M.I., Finch S., Pesci A., Dupont L.J., Fardon T.C., Wilson R., Loebinger M.R., et al. Comorbidities and the risk of mortality in patients with bronchiectasis: An international multicentre cohort study. Lancet Respir. Med. 2016;4:969–979. doi: 10.1016/S2213-2600(16)30320-4. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources